1-Methylpiperazine → HCID 58638531, compound
Reaction equation
[Cl:1][C:2]1[C:7](Cl)=[CH:6][C:5]([N:9]2[CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]2)=[C:4]([N+:15]([O-:17])=[O:16])[CH:3]=1.[CH3:18][N:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1>>[Cl:1][C:2]1[CH:3]=[C:4]([N+:15]([O-:17])=[O:16])[C:5]([N:9]2[CH2:14][CH2:13][CH2:12][CH2:11][CH2:10]2)=[CH:6][C:7]=1[N:22]1[CH2:23][CH2:24][N:19]([CH3:18])[CH2:20][CH2:21]1Participants
3
Procedure
The procedure of Example 5, step (b) was followed using 968 mg (3.52 mmol) of 1-(4,5-dichloro-2-nitro-phenyl)-piperidine (as prepared in the previous step) and 1.95 mL (17.6 mmol) of 1-methylpiperazine. Crystallization from hexane afforded 997 mg (84%) of the title compound as a yellow-tan solid: Mass spectrum (ESI, m/z): Calcd. for C16H23ClN4O2, 339.2 (M+H), found 339.1.
Workup
- customCrystallization from hexane
Sources & evidence
- ORD record
- ord-4859e666326a484389d406c78cfafdae
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07705042B2
Reaction notes
Loading…